Lanean...
TAS-102, a novel antitumor agent: a review of the mechanism of action
Inhibition of nucleoside metabolism is an important principle in cancer therapy as evidenced by the role of fluoropyrimidines, such as 5-fluorouracil (5-FU), and antifolates in the treatment of many cancers. TAS-102 is an oral combination therapy consisting of trifluridine (FTD), a thymidine-based n...
Gorde:
| Argitaratua izan da: | Cancer Treat Rev |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4624296/ https://ncbi.nlm.nih.gov/pubmed/26428513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2015.06.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|